Dennis, M., Davies, M., Oliver, S., D’Souza, R., Pike, L., & Stockman, P. (2012). Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia. Springer-Verlag.

Dennis, Mike, Michelle Davies, Stuart Oliver, Roy D’Souza, Laura Pike, and Paul Stockman. Phase I Study of the Aurora B Kinase Inhibitor Barasertib (AZD1152) to Assess the Pharmacokinetics, Metabolism and Excretion in Patients With Acute Myeloid Leukemia. Springer-Verlag, 2012.

Dennis, Mike, et al. Phase I Study of the Aurora B Kinase Inhibitor Barasertib (AZD1152) to Assess the Pharmacokinetics, Metabolism and Excretion in Patients With Acute Myeloid Leukemia. Springer-Verlag, 2012.